Imagine catching breast cancer early with a simple blood draw, no scans needed. That's the idea behind a new approach that measures specific fats in the blood and uses computer models to look for signs of cancer.
The study involved women with early-stage breast cancer and controls from international cohorts. Researchers used a 15-lipid panel and machine learning to analyze blood samples. In European cohorts, the test achieved an AUC of at least 0.94, a strong measure of accuracy. In an Australian validation cohort, it showed 76% sensitivity and 64% specificity, with an AUC of 0.81. When the models were more confident, sensitivity reached up to 89%.
This was an observational study, so it shows an association, not that the test causes better outcomes. The findings are early and need more validation before any clinical use. Safety data wasn't reported, and the study didn't track long-term results.